Late-stage biopharmaceutical company Aridis Pharmaceuticals, Inc. is pioneering the development of targeted immunotherapy using fully human monoclonal antibodies (mAb) for the treatment of life-threatening infections. The company's leading product candidate, AR-301, is a fully human mAb of immunoglobulin 1 (IgG1) that is currently in Phase III pivotal trials for the treatment of lung infections caused by S. aureus alphatoxin. In addition to AR-301, Aridis is developing other mAbs to target infections caused by a range of bacteria and viruses. These include AR-320, a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin for the treatment of infections caused by methicillin-resistant and methicillin-susceptible S. aureus; AR-105, a fully human IgG1 mAb in Phase II trials targeting gram-negative bacteria P. aeruginosa; AR-101, a human IgM mAb in Phase IIa clinical trials for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by P. aeruginosa serotype O11; AR-401, a preclinical stage treatment for infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-501, an anti-infective therapy in Phase I/IIa clinical trial for the management of chronic lung infections in cystic fibrosis patients. Furthermore, Aridis is currently developing AR-712 and AR-701, a cocktail of two fully human immunoglobulin 1 (IgG1) mAbs, which is in Phase I/II clinical trials for the treatment of mild to moderate non-hospitalized COVID-19 patients. Founded in 2003 and headquartered in Los Gatos, California, Aridis Pharmaceuticals is at the forefront of targeted immunotherapy development for the treatment of infectious diseases.
Aridis Pharmaceuticals Inc.'s ticker is ARDS
The company's shares trade on the NASDAQ stock exchange
They are based in Los Gatos, California
There are 11-50 employees working at Aridis Pharmaceuticals Inc.
It is https://www.aridispharma.com/
Aridis Pharmaceuticals Inc. is in the Healthcare sector
Aridis Pharmaceuticals Inc. is in the Biotechnology industry
The following five companies are Aridis Pharmaceuticals Inc.'s industry peers: